TaiRx
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6f-1 No.66 San-Chung Rd. Nankang Busines...Website
www.trx.com.twRevenue
$6.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About TaiRx
TaiRx, Inc. is a new drug development company focused on innovative cancer treatments, currently conducting Phase II clinical trials for its lead drug CVM-1118, which targets neuroendocrine tumors and liver cancer. The company aims to provide effective therapies for rare cancers, having recently received Orphan Drug Designation from the FDA for CVM-1118. In addition to its oncology pipeline, TaiRx also offers Zelnite, a selenium injection approved for treating selenium deficiency. Their intended clients include healthcare providers and patients seeking advanced cancer treatment options.Explore more
Popular SearchesTaiRx IncSIC Code 28,283NAICS Code 32,325Show moreTaiRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TaiRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
TaiRx, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at TaiRx
Check out if TaiRx is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if TaiRx had a recent Job posting/layoffs
Product Launch: Get notified when TaiRx launches new products
Funding: Get notified immidiatlly once TaiRx has new funding data
Check if TaiRx has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on TaiRx recently announced quarterly report
Recommended Actions
Find VP level buyers at TaiRx
Find more new buyers
Company Profile Activity
Activity Insights
TaiRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TaiRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TaiRx.
TaiRx Tech Stack
A closer look at the technologies used by TaiRx
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
TaiRx News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TaiRx
Sign Up For FreeTo access detailed company insights
TaiRx, Inc. is a new drug development company focused on innovative cancer treatments, currently conducting Phase II clinical trials for its lead drug CVM-1118, which targets neuroendocrine tumors and liver cancer. The company aims to provide effective therapies for rare cancers, having recently received Orphan Drug Designation from the FDA for CVM... Read More
